http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020162795-A2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_151389dcf21573ef2d4f96f8085cdf5b |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-105 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-175 |
| filingDate | 2020-02-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_335db59baf0086b64a05a1dd654a5ddf |
| publicationDate | 2020-08-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2020162795-A2 |
| titleOfInvention | Dietary supplement and method for the use thereof |
| abstract | The invention relates to the food industry, and more particularly to dietary supplements based on rare-earth metals conducive to maintaining the body in a healthy condition. The invention makes it possible to produce a supplement that exhibits a cardioprotective and anticancer effect. The technical result of the invention is an improvement in the absorbability of rare-earth metals and the creation of a supplement that exhibits a cardioprotective and anticancer effect. This technical result is achieved in that a dietary supplement containing the rare-earth metals europium, terbium, lutetium, erbium and thulium is claimed which is characterized in that it additionally contains aminoacetic acid (glycine), and succinic acid, wherein the metals europium, terbium, lutetium and erbium are present in the supplement in the form of chlorides, and thulium is present in the form of a nitrate, and the composition has the following ratio of ingredients: 11-25 wt% europium chloride (EuCl 3 ); 11-25 wt% terbium chloride (TbCl 3 ); 11-25 wt% lutetium chloride (LuCl 3 ); 11-25 wt% erbium chloride (ErCl 3 ); 11-25 wt% thulium nitrate (TmNO 3 ); 11-13.6 wt% succinic acid; the balance aminoacetic acid (glycine). Also claimed is a method for the use of the aforementioned dietary supplement, in which the dietary supplement compound is administered orally in daily single doses of from 25 to 125 µg/kg. |
| priorityDate | 2019-02-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 122.